Related Experiment Video
Updated: Aug 4, 2025

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
Published on: November 30, 2016
Current advancements in pharmacotherapy for cancer cachexia
Guilherme Wesley Peixoto da Fonseca1,2, Ryosuke Sato3, Maria Janieire de Nazaré Nunes Alves1
1Department of Cardiovascular Rehabilitation and Exercise Physiology, Heart Institute (Incor), University of São Paulo Medical School, São Paulo, Brazil.
Cancer cachexia is a complex metabolic syndrome. Current pharmacotherapies show limited success, but Ponsegromab, a GDF15 inhibitor, offers promise in ongoing clinical trials for treating cancer cachexia.
Area of Science:
- Oncology
- Metabolic Syndrome
- Pharmacology
Background:
- Cancer cachexia is a multifactorial syndrome characterized by metabolic dysregulation, inflammation, and anorexia.
- It leads to a negative energy balance, favoring catabolism and impacting patient outcomes.
- Therapeutic strategies have focused on nutritional support, exercise, and medications to counteract catabolism, but drug approval remains challenging.
Conclusions:
- Pharmacological therapy for cancer cachexia aims to improve body composition, muscle function, and survival.
- Current treatments have limitations in demonstrating broad efficacy.
- Ponsegromab represents a novel and promising therapeutic avenue for cancer cachexia.
More Related Videos
09:25The Treadmill Fatigue Test: A Simple, High-throughput Assay of Fatigue-like Behavior for the Mouse
Published on: May 31, 2016
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy